Cargando…

Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve-sparing radical prostatectomy: a randomized, controlled trial

OBJECTIVE: To examine the effect of penile vibratory stimulation (PVS) in the preservation and restoration of erectile function and urinary continence in conjunction with nerve-sparing radical prostatectomy (RP). PATIENTS AND METHODS: The present study was conducted between July 2010 and March 2013...

Descripción completa

Detalles Bibliográficos
Autores principales: Fode, Mikkel, Borre, Michael, Ohl, Dana A, Lichtbach, Jonas, Sønksen, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282032/
https://www.ncbi.nlm.nih.gov/pubmed/24127838
http://dx.doi.org/10.1111/bju.12501
_version_ 1782351060729331712
author Fode, Mikkel
Borre, Michael
Ohl, Dana A
Lichtbach, Jonas
Sønksen, Jens
author_facet Fode, Mikkel
Borre, Michael
Ohl, Dana A
Lichtbach, Jonas
Sønksen, Jens
author_sort Fode, Mikkel
collection PubMed
description OBJECTIVE: To examine the effect of penile vibratory stimulation (PVS) in the preservation and restoration of erectile function and urinary continence in conjunction with nerve-sparing radical prostatectomy (RP). PATIENTS AND METHODS: The present study was conducted between July 2010 and March 2013 as a randomized prospective trial at two university hospitals. Eligible participants were continent men with an International Index of Erectile Function-5 (IIEF-5) score of at least 18, scheduled to undergo nerve-sparing RP. Patients were randomized to a PVS group or a control group. Patients in the PVS group were instructed in using a PVS device (FERTI CARE® vibrator). Stimulation was performed at the frenulum once daily by the patients in their own homes for at least 1 week before surgery. After catheter removal, daily PVS was re-initiated for a period of 6 weeks. Participants were evaluated at 3, 6 and 12 months after surgery with the IIEF-5 questionnaire and questions regarding urinary bother. Patients using up to one pad daily for security reasons only were considered continent. The study was registered at http://clinicaltrials.gov/ (NCT01067261). RESULTS: Data from 68 patients were available for analyses (30 patients randomized to PVS and 38 patients randomized to the control group). The IIEF-5 score was highest in the PVS group at all time points after surgery with a median score of 18 vs 7.5 in the control group at 12 months (P = 0.09), but the difference only reached borderline significance. At 12 months, 16/30 (53%) patients in the PVS group had reached an IIEF-5 score of at least 18, while this was the case for 12/38 (32%) patients in the control group (P = 0.07). There were no significant differences in the proportions of continent patients between groups at 3, 6 or 12 months. At 12 months 90% of the PVS patients were continent, while 94.7% of the control patients were continent (P = 0.46). CONCLUSION: The present study did not document a significant effect of PVS. However, the method proved to be acceptable for most patients and there was a trend towards better erectile function with PVS. More studies are needed to explore this possible effect further.
format Online
Article
Text
id pubmed-4282032
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-42820322015-01-15 Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve-sparing radical prostatectomy: a randomized, controlled trial Fode, Mikkel Borre, Michael Ohl, Dana A Lichtbach, Jonas Sønksen, Jens BJU Int Functional Urology OBJECTIVE: To examine the effect of penile vibratory stimulation (PVS) in the preservation and restoration of erectile function and urinary continence in conjunction with nerve-sparing radical prostatectomy (RP). PATIENTS AND METHODS: The present study was conducted between July 2010 and March 2013 as a randomized prospective trial at two university hospitals. Eligible participants were continent men with an International Index of Erectile Function-5 (IIEF-5) score of at least 18, scheduled to undergo nerve-sparing RP. Patients were randomized to a PVS group or a control group. Patients in the PVS group were instructed in using a PVS device (FERTI CARE® vibrator). Stimulation was performed at the frenulum once daily by the patients in their own homes for at least 1 week before surgery. After catheter removal, daily PVS was re-initiated for a period of 6 weeks. Participants were evaluated at 3, 6 and 12 months after surgery with the IIEF-5 questionnaire and questions regarding urinary bother. Patients using up to one pad daily for security reasons only were considered continent. The study was registered at http://clinicaltrials.gov/ (NCT01067261). RESULTS: Data from 68 patients were available for analyses (30 patients randomized to PVS and 38 patients randomized to the control group). The IIEF-5 score was highest in the PVS group at all time points after surgery with a median score of 18 vs 7.5 in the control group at 12 months (P = 0.09), but the difference only reached borderline significance. At 12 months, 16/30 (53%) patients in the PVS group had reached an IIEF-5 score of at least 18, while this was the case for 12/38 (32%) patients in the control group (P = 0.07). There were no significant differences in the proportions of continent patients between groups at 3, 6 or 12 months. At 12 months 90% of the PVS patients were continent, while 94.7% of the control patients were continent (P = 0.46). CONCLUSION: The present study did not document a significant effect of PVS. However, the method proved to be acceptable for most patients and there was a trend towards better erectile function with PVS. More studies are needed to explore this possible effect further. BlackWell Publishing Ltd 2014-07 2014-01-22 /pmc/articles/PMC4282032/ /pubmed/24127838 http://dx.doi.org/10.1111/bju.12501 Text en © 2013 The Authors. BJU International published by John Wiley & Sons Ltd on behalf of BJU International. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Functional Urology
Fode, Mikkel
Borre, Michael
Ohl, Dana A
Lichtbach, Jonas
Sønksen, Jens
Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve-sparing radical prostatectomy: a randomized, controlled trial
title Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve-sparing radical prostatectomy: a randomized, controlled trial
title_full Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve-sparing radical prostatectomy: a randomized, controlled trial
title_fullStr Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve-sparing radical prostatectomy: a randomized, controlled trial
title_full_unstemmed Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve-sparing radical prostatectomy: a randomized, controlled trial
title_short Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve-sparing radical prostatectomy: a randomized, controlled trial
title_sort penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve-sparing radical prostatectomy: a randomized, controlled trial
topic Functional Urology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282032/
https://www.ncbi.nlm.nih.gov/pubmed/24127838
http://dx.doi.org/10.1111/bju.12501
work_keys_str_mv AT fodemikkel penilevibratorystimulationintherecoveryofurinarycontinenceanderectilefunctionafternervesparingradicalprostatectomyarandomizedcontrolledtrial
AT borremichael penilevibratorystimulationintherecoveryofurinarycontinenceanderectilefunctionafternervesparingradicalprostatectomyarandomizedcontrolledtrial
AT ohldanaa penilevibratorystimulationintherecoveryofurinarycontinenceanderectilefunctionafternervesparingradicalprostatectomyarandomizedcontrolledtrial
AT lichtbachjonas penilevibratorystimulationintherecoveryofurinarycontinenceanderectilefunctionafternervesparingradicalprostatectomyarandomizedcontrolledtrial
AT sønksenjens penilevibratorystimulationintherecoveryofurinarycontinenceanderectilefunctionafternervesparingradicalprostatectomyarandomizedcontrolledtrial